Updated Jul 16, 2026 · Last SEC filing 2026-06-04
LEXICON PHARMACEUTICALS, INC. (LXRX) has filed 15 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-04. 2 Form 8-K material event filings were reported by LXRX in the last 90 days. InsiderAlpha tracks every LXRX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001062822 |
|---|
| Form 4 filings (90d) | 15 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-06-04 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sullivan Diane E. | Director | M — Option exercise | 89.3K | $0.00 | — | SEC | |
| Cheung Ivan | Director | M — Option exercise | 89.3K | $0.00 | — | SEC | |
| DEBBANE RAYMOND | Director | M — Option exercise | 89.3K | $0.00 | — | SEC | |
| Amouyal Philippe | Director | M — Option exercise | 89.3K | $0.00 | — | SEC | |
| Swain Judith L | Director | M — Option exercise | 89.3K | $0.00 | — | SEC | |
| BARKER SAM L | Director | M — Option exercise | 89.3K | $0.00 | — | SEC | |
| SOBECKI CHRISTOPHER J | Director | M — Option exercise | 89.3K | $0.00 | — | SEC | |
| Artal Participations S.a r.l. | Insider | M — Option exercise | 20.42M | $0.00 | — | SEC | |
| Granowitz Craig B | SVP, Chief Medical Officer | M — Option exercise | 202.3K | — | — | SEC | |
| McDermott Wendy | SVP, Human Resources | M — Option exercise | 27.7K | — | — | SEC | |
| Granowitz Craig B | SVP, Chief Medical Officer | M — Option exercise | 74.2K | — | — | SEC | |
| McDermott Wendy | SVP, Human Resources | M — Option exercise | 52.3K | — | — | SEC | |
| McDermott Wendy | SVP, Human Resources | M — Option exercise | 144.4K | — | — | SEC | |
| McDermott Wendy | SVP, Human Resources | F — Tax withholding / forfeiture | 68.1K | $1.47 | $100K | SEC | |
| Granowitz Craig B | SVP, Chief Medical Officer | F — Tax withholding / forfeiture | 109.1K | $1.47 | $160K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for LEXICON PHARMACEUTICALS, INC. (LXRX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| DEBBANE RAYMOND | 4 | — |
| SOBECKI CHRISTOPHER J | 4 | — |
| BARKER SAM L | 4 | — |
| Amouyal Philippe | 4 | — |
| Sullivan Diane E. | 4 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in LXRX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live LXRX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.